Authors:
Ibrahim, NK
Valero, V
Rahman, Z
Theriault, RL
Walters, RS
Buzdar, AU
Booser, DJ
Holmes, FA
Murray, DJ
Willey, J
Bast, R
Hortobagyi, GN
Citation: Nk. Ibrahim et al., Phase I-II vinorelbine (Navelbine((R))) by continuous infusion in patientswith metastatic breast cancer: Cumulative toxicities limit dose escalation, CANCER INV, 19(5), 2001, pp. 459-466
Authors:
Rivera, E
Valero, V
Syrewicz, L
Rahman, Z
Esteva, FL
Theriault, RL
Rosales, MM
Booser, D
Murray, JL
Bast, RC
Hortobagyi, GN
Citation: E. Rivera et al., Phase I study of stealth liposomal doxorubicin in combination with gemcitabine in the treatment of patients with metastatic breast cancer, J CL ONCOL, 19(6), 2001, pp. 1716-1722
Authors:
Rahman, Z
Yoshikawa, H
Nakajima, Y
Tasaka, K
Citation: Z. Rahman et al., Down-regulation of Pim-1 and Bcl-2 is accompanied with apoptosis of interleukin-6-depleted mouse B-cell hybridoma 7TD1 cells, IMMUNOL LET, 75(3), 2001, pp. 199-208
Authors:
Weiss, MA
Glenn, M
Maslak, P
Rahman, Z
Noy, A
Zelenetz, A
Scheinberg, DA
Golde, DW
Citation: Ma. Weiss et al., Consolidation therapy with high-dose cyclophosphamide improves the qualityof response in patients with chronic lymphocytic leukemia treated with fludarabine as induction therapy, LEUKEMIA, 14(9), 2000, pp. 1577-1582
Authors:
Rahman, Z
Gold, SJ
Potenza, MN
Cowan, CW
Ni, YG
He, W
Wensel, TG
Nestler, EJ
Citation: Z. Rahman et al., Cloning and characterization of RGS9-2: A striatal-enriched alternatively spliced product of the RGS9 gene, J NEUROSC, 19(6), 1999, pp. 2016-2026
Authors:
Ibrahim, NK
Rahman, Z
Valero, V
Willey, J
Theriault, RL
Buzdar, AU
Murray, JL
Bast, R
Hortobagyi, GN
Citation: Nk. Ibrahim et al., Phase II study of vinorelbine administered by 96-hour infusion in patientswith advanced breast carcinoma, CANCER, 86(7), 1999, pp. 1251-1257